Tag: Bispecific

Bispecific Antibodies Market size was valued at USD 0.58 billion in 2023 and expected to reach USD 0.95 billion by 2030, at ...

SAN DIEGO -- A bispecific immune checkpoint inhibitor significantly improved survival in advanced gastric/gastroesophageal junction (GEJ) cancer, irrespective of PD-L1 ...

The FDA has granted accelerated approval to glofitamab (Columvi) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), ...